Question
Our pharmaceutical company now received 47 complaints about the new pain reliever NoPain, created in your lab. Of the 47 complaints, 24 said their headache
Our pharmaceutical company now received 47 complaints about the new pain reliever NoPain, created in your lab. Of the 47 complaints, 24 said their headache got worse, 15 said they had severe cramping after taking the medication, and 8 said they had both problems. We have only been distributing this pain reliever for about 30 days and we are very concerned. It has cost our company roughly 1.2 million dollars to create the drug and we have recorded sales of $98,600 in the past month at $10 a bottle, so that is 9,860 bottles. Should we be concerned? Do you think we should pull the product and conduct more research? We may end up losing money on this if we pursue this course of action. Should we keep the product on the shelves and secretly do more research? Or should we just do nothing for the time being, wait it out, and see what happens? Please get back to us as soon as possible with your recommendation.
Using your basic mathematical skills, calculate how long it will take the pharmaceutical company to earn back the amount that it had invested, if it continues to sell the product at the current selling rate.
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started